(Q37689573)

English

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis

scientific article published on 09 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

22 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Shu-zhen Wei

1

1 reference

Europe PubMed Central

22 August 2017

Ping Zhan

2

1 reference

Europe PubMed Central

22 August 2017

Mei-qi Shi

3

1 reference

Europe PubMed Central

22 August 2017

Yi Shi

4

1 reference

Europe PubMed Central

22 August 2017

Qian Qian

5

1 reference

Europe PubMed Central

22 August 2017

Li-ke Yu

6

1 reference

Europe PubMed Central

22 August 2017

Yong Song

7

1 reference

Europe PubMed Central

22 August 2017

publication date

9 February 2010

1 reference

Europe PubMed Central

22 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Medical Oncology

1 reference

Europe PubMed Central

22 August 2017

28

1 reference

Europe PubMed Central

22 August 2017

315-321

1 reference

Europe PubMed Central

22 August 2017

1

1 reference

Europe PubMed Central

22 August 2017

https://scigraph.springernature.com/pub.10.1007/s12032-010-9443-1

0 references

Chemotherapy in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Xpd/Ercc2 regulates CAK activity and mitotic progression

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Molecular predictors of response to chemotherapy in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Genomic signatures to guide the use of chemotherapeutics.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

The use and development of germline polymorphisms in clinical oncology.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Mechanism of open complex and dual incision formation by human nucleotide excision repair factors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9443-1

21 January 2018

DNA repair and survival in lung cancer--the two faces of Janus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphisms in DNA repair genes and associations with cancer risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA repair: a double-edged sword

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-010-9443-1

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37689573&oldid=2092822096"